OpenClinica Featured in ‘In Depth’ Educational TV Series - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

OpenClinica Featured in ‘In Depth’ Educational TV Series

OpenClinica is pleased to announce that it will be included in public television series In Depth, exhibiting its clinical trials and technology that assists with effective and safe vaccines, medications and medical devices.

The OpenClinica segment is designed to educate the public about modern, technology-enabled clinical trials. Hosted by renowned actor Laurence Fishburne, the program brings awareness to topics that affect people around the globe today and spotlights organisations leading the advancement of technologies within their industry.

“Perhaps one of the silver linings of the Covid-19 pandemic is increased public attention on clinical research,” said OpenClinica CEO Cal Collins. “We are grateful to have the opportunity to enhance public education about clinical research.”

With the Coronavirus, constant pandemic headlines, and most recently, the successful Covid-19 vaccines from Pfizer, Moderna, and AstraZeneca, the subject of clinical trials has been thrust into the global media spotlight. As people become increasingly aware of clinical trials, there is a need to underscore the critical process of capturing high-quality, reliable, and statistically sound data. This data enables pharmaceutical and research companies to develop new vaccines, medicines, and medical devices that are safe and effective for clinical trial volunteers and the global population.

According to Mr Collins: “Clinical research is incredibly complex. It typically takes years and a large team of dedicated people, to bring a new treatment to market. The fact that so many vaccines, diagnostics, and therapies were approved and put into use in under a year may seem like a miracle. It’s been possible in large part due to technology, process innovation, and a willingness to think differently about how we approach the research process. We’re moving much faster, and we’re also getting better data at the same time. It is my hope that this sort of approach will soon become the norm for many treatments, rather than the exception.”

Powerful eClinical technology is essential to handling diseases like Covid-19, which are becoming more complex and the amount of research data becomes greater and greater. OpenClinica is proud to be powering Covid-19 research with organisations such as Oxford University, Quantum Leap Healthcare, Butantan Institute, McGill University, Imperial College of London and more.

For more information, please fill out the enquiry form attached to this page.

More About This Company